ACADIA Pharmaceuticals (ACAD) has drawn investor attention after recent share price moves, with the stock down around 2% over ...
ACADIA Pharmaceuticals Inc. Annual stock financials by MarketWatch. View the latest ACAD financial statements, income statements and financial ratios.
Zacks Investment Research on MSN
FTRE vs. ACAD: Which stock is the better value option?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Fortrea Holdings Inc. (FTRE) or Acadia Pharmaceuticals (ACAD). But which of these two ...
Acadia Pharmaceuticals (ACAD) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC requires all ...
ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) stock jumped 26.6% to $22.29 on Friday afternoon following a favorable court ruling. What To Know: The U.S. District Court for the District of Delaware upheld ...
The latest price target for ACADIA Pharmaceuticals (NASDAQ:ACAD) was reported by HC Wainwright & Co. on December 15, 2025. The analyst firm set a price target for $37.00 expecting ACAD to rise to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback